These patients shared specific clinical features, some of which are also present in patients with the ASXL1 gene (BOS) and ASXL3 gene (BRS) truncating or splicing pathogenic variants (developmental and intellectual impairment, facial dimorphism, feeding difficulties in the neonatal period and hypotonia). Here, ASXL1 is linked to Cognitive impairment.